Evaluation of Cyclosporine for the Treatment of DRESS Syndrome.
Journal articles
- Letter
Nguyen, E; Yanes, D; Imadojemu, S; Kroshinsky, D
Published in: JAMA Dermatol
June 1, 2020
This retrospective case-control study of 26 adults evaluates the use of cyclosporine A in the treatment of drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) compared with standard systemic glucocorticosteroids.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
June 1, 2020
Volume
156
Issue
6
Start / End Page
704 / 706
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Severity of Illness Index
- Retrospective Studies
- Middle Aged
- Methylprednisolone
- Male
- Humans
- Female
- Drug Hypersensitivity Syndrome
Citation
APA
Chicago
ICMJE
MLA
NLM
Nguyen, E., Yanes, D., Imadojemu, S., & Kroshinsky, D. (2020). Evaluation of Cyclosporine for the Treatment of DRESS Syndrome. JAMA Dermatol, 156(6), 704–706. https://doi.org/10.1001/jamadermatol.2020.0048
Nguyen, Emily, Daniel Yanes, Sotonye Imadojemu, and Daniela Kroshinsky. “Evaluation of Cyclosporine for the Treatment of DRESS Syndrome.” JAMA Dermatol 156, no. 6 (June 1, 2020): 704–6. https://doi.org/10.1001/jamadermatol.2020.0048.
Nguyen E, Yanes D, Imadojemu S, Kroshinsky D. Evaluation of Cyclosporine for the Treatment of DRESS Syndrome. JAMA Dermatol. 2020 Jun 1;156(6):704–6.
Nguyen, Emily, et al. “Evaluation of Cyclosporine for the Treatment of DRESS Syndrome.” JAMA Dermatol, vol. 156, no. 6, June 2020, pp. 704–06. Pubmed, doi:10.1001/jamadermatol.2020.0048.
Nguyen E, Yanes D, Imadojemu S, Kroshinsky D. Evaluation of Cyclosporine for the Treatment of DRESS Syndrome. JAMA Dermatol. 2020 Jun 1;156(6):704–706.
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
June 1, 2020
Volume
156
Issue
6
Start / End Page
704 / 706
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Severity of Illness Index
- Retrospective Studies
- Middle Aged
- Methylprednisolone
- Male
- Humans
- Female
- Drug Hypersensitivity Syndrome